Two cancer stem cell-targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model

被引：8
|
作者：
Caras, Ingrid W. [1 ]
机构：
[1] Calif Inst Regenerat Med, 1999 Harrison St, Oakland, CA 94612 USA
来源：
STEM CELLS TRANSLATIONAL MEDICINE | 2020年 / 9卷 / 08期
关键词：
ACUTE MYELOID-LEUKEMIA; ROR1; CD47; RITUXIMAB; PHAGOCYTOSIS; MACROPHAGES; SIGNATURE;
D O I：
10.1002/sctm.19-0424
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
A key implication of the cancer stem cell model is that for a cancer therapy to be curative, it is imperative to eliminate the cancer stem cells (CSCs) that drive tumor progression. The California Institute for Regenerative Medicine is supporting two novel approaches that target CSCs, one an antibody-mediated immunotherapy targeting CD47 and the other an antibody targeting ROR1. This article summarizes the evidence that CSCs are targeted and discusses the results of early clinical trials within the context of the CSC model.
引用
收藏
页码：821 / 826
页数：6
相关论文
共 50 条
  • [31] Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies
    Frank, Markus H.
    Wilson, Brian J.
    Gold, Jason S.
    Frank, Natasha Y.
    GASTROENTEROLOGY, 2021, 160 (06) : 1947 - 1960
  • [32] From Cell Stem Cell to Clinical Trials: The Biotech Journey of Two Papers
    Crow, Diana
    CELL STEM CELL, 2017, 20 (06) : 746 - 748
  • [33] A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy
    Han, Yu Kyeong
    Lee, Jae Ho
    Park, Ga-Young
    Chun, Sung Hak
    Han, Jeong Yun
    Kim, Sung Dae
    Lee, Janet
    Lee, Chang-Woo
    Yang, Kwangmo
    Lee, Chang Geun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (04) : 1329 - 1333
  • [34] Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
    Wolf, Isis
    Gratzke, Christian
    Wolf, Philipp
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] The Stem Cell Network model: clinical implications in cancer
    Cabanillas, Ruben
    Llorente, Jose L.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2009, 266 (02) : 161 - 170
  • [36] The Stem Cell Network model: clinical implications in cancer
    Rubén Cabanillas
    José L. Llorente
    European Archives of Oto-Rhino-Laryngology, 2009, 266 : 161 - 170
  • [37] Tumour stem cell-targeted treatment: elimination or differentiation
    Massard, C.
    Deutsch, E.
    Soria, J. -C.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1620 - 1624
  • [38] Induction of Cancer Stem Cell Markers Following Treatment with Molecularly Targeted Therapies in Epithelial Ovarian Cancer Cell Lines
    Pathak, Harsh B.
    Hirst, Jeff
    Godwin, Andrew K.
    JOURNAL OF WOMENS HEALTH, 2016, 25 (09) : 969 - 969
  • [39] Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke
    Michael G. Liska
    Marci G. Crowley
    Cesar V. Borlongan
    Translational Stroke Research, 2017, 8 : 93 - 103
  • [40] Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke
    Liska, Michael G.
    Crowley, Marci G.
    Borlongan, Cesar V.
    TRANSLATIONAL STROKE RESEARCH, 2017, 8 (02) : 93 - 103
12345